Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.97 USD | -0.26% | -1.30% | -9.27% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.27% | 12.82B | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.42% | 16.72B | |
-25.92% | 15.09B | |
-7.57% | 11.95B | |
+0.07% | 8.71B | |
-11.81% | 7.97B |
- Stock
- Equities
- Stock Incyte Corporation - Nasdaq
- News Incyte Corporation
- Incyte : Review Period for Incyte's Ruxolitinib New Drug Application Extended by FDA